Jane Street’s OncoSec Medical Incorporated ONCS Stock Holding History

Jane Street’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-96	Closed	-$12K	–	6121
2019 Q1	$12K	Buy	+96	New	+$13.1K	﹤0.01%	4917
2018 Q4	–	Sell	-48	Closed	-$15K	–	6172
2018 Q3	$15K	Buy	+48	New	+$14.8K	﹤0.01%	4984

Other funds holding ONCS

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jane Street's ONCS Position: Q2 2019 in Review

Jane Street sold out of OncoSec Medical Incorporated (ONCS) in Q2 2019, closing a stake of 96 shares — an estimated $12K sold.

Jane Street first reported a position in ONCS in Q3 2018 and held it in 2 quarters. The position peaked at $15K in Q3 2018. 20 funds tracked by Wall St. Rank hold ONCS as of Q2 2019.

Jane Street reported no remaining OncoSec Medical Incorporated position as of Q2 2019 after selling out during the quarter.
Jane Street sold 96 OncoSec Medical Incorporated shares in Q2 2019, an estimated $12K.
Jane Street first reported a position in OncoSec Medical Incorporated in Q3 2018 and held it in 2 quarters.
Jane Street's OncoSec Medical Incorporated position peaked at $15K in Q3 2018.
20 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2019.

Based on Jane Street's 13F filing for Q2 2019, filed 15 Aug 2019.